What is included in the long-term monitoring following treatment of mycobacterium chelonae infection?

Updated: Dec 20, 2018
  • Author: Alfred Scott Lea, MD; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print

The frequency of outpatient visits is determined by the extent of the disease, its sequelae, and whether the patient is receiving oral or intravenous therapy. Initially, patients on oral antibiotics should be evaluated at least monthly for signs of adverse events. More frequent visits may be necessary for patients with parenteral therapy and intravascular catheters to evaluate for complications and line infections.

Outpatients taking aminoglycoside therapy should undergo periodic (at least weekly) assessment of renal function, hearing, and antibiotic levels to avoid toxicity.

Monthly sputum cultures are recommended in patients with pulmonary disease to determine the efficacy and duration of therapy.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!